ASMB insider filings

ASSEMBLY BIOSCIENCES, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen ASMB transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Okazaki Jason A — CEO and President, Director1—2 legs · 6,202 sh · $121,6581
Gaggar Anuj — Chief Medical Officer1—2 legs · 2,593 sh · $50,8641
White Nicole S — Chief Manufacturing Officer1—2 legs · 2,593 sh · $50,8641
Bjorkquist Jeanette M — PFO and PAO1—2 legs · 727 sh · $14,2611
Delaney William E IV — Chief Scientific Officer1——1

Recent insider filings — ASSEMBLY BIOSCIENCES, INC.

FiledFormInsiderReported transactionsSource
2026-11-034Bjorkquist Jeanette M — PFO and PAOGrant/award (A): 3,840 @ $0 · Sale (S): 718 @ $19.61 · Sale (S): 9 @ $20.35EDGAR
2026-11-034White Nicole S — Chief Manufacturing OfficerGrant/award (A): 13,705 @ $0 · Sale (S): 2,564 @ $19.61 · Sale (S): 29 @ $20.35EDGAR
2026-11-034Delaney William E IV — Chief Scientific OfficerGrant/award (A): 13,705 @ $0EDGAR
2026-11-034Gaggar Anuj — Chief Medical OfficerGrant/award (A): 13,705 @ $0 · Sale (S): 2,564 @ $19.61 · Sale (S): 29 @ $20.35EDGAR
2026-11-034Okazaki Jason A — CEO and President, DirectorGrant/award (A): 38,380 @ $0 · Sale (S): 6,133 @ $19.61 · Sale (S): 69 @ $20.35EDGAR
2026-06-184Bjorkquist Jeanette M — PFO and PAOSale (S): 29 @ $23.25EDGAR
2026-06-054Gaggar Anuj — Chief Medical OfficerGrant/award (A): 14,000 @ $0EDGAR
2026-06-054White Nicole S — Chief Manufacturing OfficerGrant/award (A): 14,000 @ $0EDGAR
2026-06-054McHutchison John G — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-06-054Mahony Susan — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-06-054Johnson-Pratt Lisa — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-06-054Houghton Michael — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-06-054Consylman Gina — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-06-054Bjorkquist Jeanette M — PFO and PAOGrant/award (A): 3,500 @ $0EDGAR
2026-06-054Delaney William E IV — Chief Scientific OfficerGrant/award (A): 14,000 @ $0EDGAR
2026-06-054Okazaki Jason A — CEO and President, DirectorGrant/award (A): 50,750 @ $0EDGAR
2026-06-054ALTIG ANTHONY E — DirectorGrant/award (A): 8,000 (derivative) @ $0EDGAR
2026-05-274GILEAD SCIENCES, INC. — 10% ownerGrant/award (A): 471,698 @ $26.50EDGAR
2026-03-314Bjorkquist Jeanette M — PFO and PAOGrant/award (A): 6,500 @ $0 · Sale (S): 312 @ $26.65 · Sale (S): 16 @ $27.49EDGAR
2026-03-314White Nicole S — Chief Manufacturing OfficerGrant/award (A): 26,000 @ $0 · Sale (S): 188 @ $26.65 · Sale (S): 9 @ $27.49EDGAR
2026-03-314Gaggar Anuj — Chief Medical OfficerGrant/award (A): 26,000 @ $0EDGAR
2026-03-314Delaney William E IV — Chief Scientific OfficerGrant/award (A): 26,000 @ $0EDGAR
2026-03-314Okazaki Jason A — CEO and President, DirectorGrant/award (A): 94,250 @ $0EDGAR
2025-10-034GILEAD SCIENCES, INC. — 10% ownerPurchase (P): 2,295,920 · Purchase (P): 1,147,960 (derivative) · Purchase (P): 1,147,960 (derivative)EDGAR
2025-06-174Bjorkquist Jeanette M — PFO and PAOGrant/award (A): 300 @ $0 · Grant/award (A): 600 (derivative) @ $0EDGAR
2025-06-094Houghton Michael — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094Mahony Susan — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094McHutchison John G — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094Johnson-Pratt Lisa — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094Consylman Gina — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094RINGO WILLIAM R — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-06-094ALTIG ANTHONY E — DirectorGrant/award (A): 3,500 (derivative) @ $0EDGAR
2025-04-154McHutchison John G — DirectorSale (S): 757 @ $9.85EDGAR
2025-04-014Delaney William E IV — Chief Scientific OfficerGrant/award (A): 25,500 (derivative) @ $0EDGAR
2025-04-014Bjorkquist Jeanette M — Principal Accounting OfficerGrant/award (A): 1,655 @ $0 · Sale (S): 180 @ $9.85 · Grant/award (A): 1,900 (derivative) @ $0EDGAR
2025-04-014Okazaki Jason A — CEO and President, DirectorSale (S): 355 @ $9.85 · Grant/award (A): 71,100 (derivative) @ $0EDGAR
2025-04-014White Nicole S — Chief Manufacturing OfficerSale (S): 197 @ $9.85 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2025-04-014Gaggar Anuj — Chief Medical OfficerGrant/award (A): 24,200 (derivative) @ $0EDGAR
2024-12-314Houghton Michael — DirectorPurchase (P): 3,202 @ $15.61EDGAR
2024-12-234GILEAD SCIENCES, INC. — 10% ownerPurchase (P): 940,499 @ $21.37EDGAR
2024-11-264Schornstein Alexander — 10% ownerPurchase (P): 17,024 @ $14.87 · Purchase (P): 2,976 @ $15 · Purchase (P): 5,000 @ $14.85EDGAR
2024-11-194White Nicole S — Chief Manufacturing OfficerSale (S): 40 @ $16.29EDGAR
2024-10-094Schornstein Alexander — 10% ownerPurchase (P): 10,000 @ $14.58EDGAR
2024-10-044White Nicole S — Chief Manufacturing OfficerSale (S): 157 @ $14.81EDGAR
2024-10-044Okazaki Jason A — CEO and President, DirectorSale (S): 197 @ $14.81EDGAR
2024-08-054White Nicole S — Chief Manufacturing OfficerSale (S): 785 @ $14.23EDGAR
2024-08-054Okazaki Jason A — CEO and President, DirectorSale (S): 981 @ $14.23EDGAR
2024-07-084Schornstein Alexander — 10% ownerPurchase (P): 4,562 @ $12.29 · Purchase (P): 4,438 @ $12.52EDGAR
2024-06-204GILEAD SCIENCES, INC. — 10% ownerPurchase (P): 179,500 · Purchase (P): 179,500 (derivative)EDGAR
2024-05-304ALTIG ANTHONY E — DirectorGrant/award (A): 2,750 (derivative) @ $0EDGAR

Recent 8-K events — ASSEMBLY BIOSCIENCES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K/A2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.01 — Completion of Acquisition or Disposition of Assets
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-268-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-228-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-088-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ASMB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs